taken “timely and effective”
to tackle any possible disruptions in supply
drugs during the COVID-19 pandemic and ensured their seamless
availability across the country, Parliament was informed on Friday.
of Pharmaceuticals (DoP) has
drugs at reasonable prices during the COVID-19 pandemic,” Minister
of Chemicals and Fertilizers D V Sadananda Gowda said in reply
to a question in the Rajya Sabha.
of the measuresÂ
taken by the government, Gowda said a ‘control room’ has been set up with a helpline number and “issues like non-
of medicines, masks, gloves, hand sanitisers etc”, and price violation in the case
essential items were resolved promptly.
An inter-ministerial committee under the chairmanship of Central
Drugs Standard Control Organisation (CDSCO) Joint Drug Controller S Eswara Reddy has been constituted
to monitor trends
of export and import
of APIs (active pharmaceutical ingredients), formulations and medical devices
ensure their timely
availability in the country and
to prevent shortages, he added.
The committee submits its reports from time
to time, Gowda said.
drugs has been ensured by coordinating with state health authorities like state drug controllers (SDCs) and central government authorities including CDSCO and the Directorate General
of Health Services (DGHS), he said while detailing about the government’s “timely and effective
measures” in this regard.
The National Pharmaceutical Pricing Authority (NPPA) under the DoP collected the critical information from drug manufacturers that was used in decision making
availability, Gowda said.
About the other
measures, he said that “steps have been
of Heparin used in COVID-19 treatment. Further, on intervention in the issue
of N-95 masks by the NPPA, major manufacturers, importers
of N-95 Masks have reduced their prices significantly up
to 67 per cent”.
The DoP also coordinated on issues related
of raw material, medicines, medical devices, packaging material etc, he said.
It also ensured seamless movement
of raw materials, packing materials, finished goods, manpower among other things
of life saving
drugs during the lockdown, Gowda said.
“The NPPA has
of life saving
drugs such as hydroxychloroquine, paracetamol, vaccines, anti-tuberculosis
drugs, imported anti-epileptic
drugs,” the minister explained.
Further, on the intervention
of the DoP, manufacturers
of Remdesivir have created a helpline
to make the drug available, Gowda said.